Opioids, pain management and the law
- PMID: 22914352
- DOI: 10.1097/ACO.0b013e328357a24a
Opioids, pain management and the law
Abstract
Purpose of review: Approximately 100 million people suffer from chronic pain in the USA. Opioid medications are commonly prescribed to treat pain, but are becoming the most widely misused controlled substance nationally. Physicians who treat patients with chronic pain must be cognizant of the federal and state policies that govern the distribution of opioid medications as well as the current standards of medical practice for opioid prescribing.
Recent findings: The laws and policies regarding the standard medical practice for opioid prescribing are constantly subject to revision. The National Drug Control Policy announced its plan to fight prescription drug abuse in 2011 and unveiled the Risk Evaluation and Management Strategy initiative. Currently there is a Risk Evaluation and Management Strategy for Transmucosal Immediate-Release Fentanyl. Other resources, such as state-run prescription drug monitoring programs, are also available to many physicians. The level of participation in these programs by physicians and pharmacists varies by state, and funding for continuation of these programs is an ongoing issue.
Summary: The problems of undertreated pain and the epidemic of prescription drug abuse have coincided, creating a need for medical and social policy that protects society and access to appropriate care for those in pain. Federal and state laws are in evolution, and clinicians must remain aware of these changes as well as the issues behind them that will impact safe and appropriate care of patients in pain.
Similar articles
-
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.Pain Physician. 2012 Jul;15(3 Suppl):S1-65. Pain Physician. 2012. PMID: 22786448
-
Managing co-occurring substance use and pain disorders.Psychiatr Clin North Am. 2012 Jun;35(2):393-409. doi: 10.1016/j.psc.2012.03.006. Epub 2012 May 5. Psychiatr Clin North Am. 2012. PMID: 22640762
-
Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.Pain Physician. 2012 Jul;15(3 Suppl):ES67-92. Pain Physician. 2012. PMID: 22786463 Review.
-
Opioid epidemic in the United States.Pain Physician. 2012 Jul;15(3 Suppl):ES9-38. Pain Physician. 2012. PMID: 22786464 Review.
-
National drug control policy and prescription drug abuse: facts and fallacies.Pain Physician. 2007 May;10(3):399-424. Pain Physician. 2007. PMID: 17525776 Review.
Cited by
-
The Use of Conditioning Open-Label Placebo in Opioid Dose Reduction: A Case Report and Literature Review.Front Pain Res (Lausanne). 2021 Jul 12;2:697475. doi: 10.3389/fpain.2021.697475. eCollection 2021. Front Pain Res (Lausanne). 2021. PMID: 35295534 Free PMC article.
-
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States.Front Pharmacol. 2021 Aug 26;12:729220. doi: 10.3389/fphar.2021.729220. eCollection 2021. Front Pharmacol. 2021. PMID: 34512353 Free PMC article.
-
Advances in the use of local anesthetic extended-release systems in pain management.Drug Deliv. 2024 Dec;31(1):2296349. doi: 10.1080/10717544.2023.2296349. Epub 2023 Dec 21. Drug Deliv. 2024. PMID: 38130151 Free PMC article. Review.
-
Government Legislation in Response to the Opioid Epidemic.Curr Pain Headache Rep. 2019 May 1;23(6):40. doi: 10.1007/s11916-019-0781-1. Curr Pain Headache Rep. 2019. PMID: 31044343 Review.
-
Targeting practitioners: A review of guidelines, training, and policy in pain management.Drug Alcohol Depend. 2017 Apr 1;173 Suppl 1(Suppl 1):S22-S30. doi: 10.1016/j.drugalcdep.2016.08.641. Drug Alcohol Depend. 2017. PMID: 28363316 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials